A Randomized Controlled Trial to Compare the Safety and Efficacy of XXXX and @entity9940 in Relieving Double J Stent Related Symptoms.

@entity1 @entity458 @entity9498 @entity2531 @entity158 @entity9940
Objectives. To evaluate the safety and efficacy of @entity9498 and @entity9940 in treating Double J stent related symptoms. Methods. In a prospective study, 161 @entity1 with DJ related symptoms were randomized into 3 groups: Group A @entity1 (54), Group B @entity1 (53), and Group C @entity1 (54). They were given @entity9498 , @entity9940 , and placebo, respectively, at 1st week till removal of DJ stent at 3rd week. All @entity1 completed Ureteral Stent Symptom Questionnaire (USSQ) at 1st week and at 3rd week. The statistical significant difference among groups was determined by the t-test, Kruskal-Wallis test and multivariate analysis were used to assess association of the variables within the three groups, and the level of significance was set at P < 0.05. Results. @entity9498 and @entity9940 were comparable in relieving urinary symptoms, general health, and work performance (OR = 0.65, 1.8, and 0.92). But @entity9498 was more effective in relieving body @entity158 , @entity458 , and additional problems than @entity9940 (OR = 5.95, 19.25, and 2.69) and was statistically significant as P < 0.05. Conclusion. @entity9498 was as effective as @entity9940 in relieving urinary symptom but more effective in relieving @entity2531 .
